Kingsview Wealth Management’s Sanofi SNY Stock Holding History

Kingsview Wealth Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$306K	Buy	6,357 +71	+1%	+$3.31K	﹤0.01%	1076
2025 Q4	$305K	Buy	6,286 +53	+0.9%	+$2.63K	﹤0.01%	1016
2025 Q3	$294K	Sell	6,233 -405	-6%	-$19.5K	﹤0.01%	969
2025 Q2	$321K	Buy	6,638 +702	+12%	+$35.9K	0.01%	913
2025 Q1	$329K	Buy	5,936 +55	+0.9%	+$2.98K	0.01%	857
2024 Q4	$284K	Sell	5,881 -20	-0.3%	-$1.02K	0.01%	923
2024 Q3	$340K	Buy	5,901 +794	+16%	+$42.9K	0.01%	841
2024 Q2	$248K	Buy	+5,107	New	+$246K	0.01%	912

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Kingsview Wealth Management's SNY Position: Q1 2026 in Review

Kingsview Wealth Management increased its Sanofi (SNY) stake by 1.1% in Q1 2026, buying an estimated $3.31K and bringing the position to 6,357 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #1076.

Kingsview Wealth Management first reported a position in SNY in Q2 2024 and has held it in 8 quarters since. The position peaked at $340K in Q3 2024. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Kingsview Wealth Management held 6,357 shares of Sanofi worth $306K as of Q1 2026.
Kingsview Wealth Management bought 71 Sanofi shares in Q1 2026, an estimated $3.31K.
Sanofi made up ﹤0.01% of Kingsview Wealth Management's portfolio in Q1 2026, its #1076 holding.
Kingsview Wealth Management first reported a position in Sanofi in Q2 2024 and has held it in 8 quarters since.
Kingsview Wealth Management's Sanofi position peaked at $340K in Q3 2024.
737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.